Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Hepatitis B
2
Química clínica
2
Aspectos moleculares
1
Carcinogénesis química
1
Cáncer
1
Difteria
1
Enfermedades transmisibles
1
Epidemiología
1
Español
1
Hepatitis
1
Hepatitis A.
1
Hepatitis B.
1
Hepatitis C
1
Influenza
1
Inglés
1
Modelos matemáticos
1
Prevención y control
1
Tetanos
1
Tos Ferina
1
Tétanos
1
-
821“…Even, marginal grafts from anti-HBc positive donors can be safely used in hepatitis B surface antigen (HBsAg) negative, preferably in anti-hepatitis B core (HBc)/anti-hepatitis B surface (HBs) positive recipients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
822por Geier, David A., Kern, Janet K., Hooker, Brian S., Sykes, Lisa K., Geier, Mark R.“…Some studies have implicated mercury (Hg) exposure as a risk factor. (2) Methods: This hypothesis testing study; using the Vaccine Safety Datalink; assessed the toxicological effects of bolus exposure to organic-Hg from Thimerosal-containing vaccines (TCVs) by examining the relationship between Thimerosal-preserved hepatitis B vaccines (TM-HepB) given at varying levels and at specific intervals in the first six months after birth and the risk of a child being diagnosed with HKSoC. (3) Results: Children diagnosed with HKSoC were significantly more likely to be exposed to increased organic-Hg from TM-HepB doses given within the first month (odds ratio = 1.45; 95% confidence interval (CI) = 1.30–1.62); within the first two months (odds ratio = 1.43; 95% CI = 1.28–1.59); and within the first six months (odds ratio = 4.51; 95% CI = 3.04–6.71) than controls. (4) Conclusion: The results indicate that increasing organic-Hg exposure from TCVs heightens the risk of a HKSoC diagnosis.…”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
823por Abreu, Rodrigo Martins, da Silva Ferreira, Camila, Ferreira, Aline Siqueira, Remor, Eduardo, Nasser, Paulo Dominguez, Carrilho, Flair José, Ono, Suzane Kioko“…INTRODUCTION: Evidence shows that treatment for hepatitis B virus (HBV) can suppress viral load. Among the factors directly linked to therapeutic success is adherence to the treatment. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
824por Al-Qudari, Ahmed Y., Amer, Haitham M., Abdo, Ayman A., Hussain, Zahid, Al-Hamoudi, Waleed, Alswat, Khalid, Almajhdi, Fahad N.“…BACKGROUND/AIMS: Hepatitis B virus (HBV) continues to be one of the most important viral pathogens in humans. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
825
-
826por ISHIKAWA, TETSUYA“…Hepatitis B virus (HBV) is susceptible to the cellular immune responses, especially to the signal of interferon (IFN)-γ. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
827por Keten, Derya, Emin Ova, Mehmet, Sirri Keten, Hamit, Keten, Alper, Gulderen, Evrim, Tumer, Seray, Caliskan, Ahmet, Kulotu, Suleyman“…BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are among the most important health issues in Turkey. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
828“…BACKGROUND/AIM: The aim of this study was to investigate the factors that influence hepatitis B virus (HBV) expression and replication in the ovum. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
829“…Hepatitis B virus (HBV) is prevalent worldwide and causes liver diseases, including acute and chronic hepatitis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
830por Yau, Alan Hoi Lun, Ford, Jo-Ann, Kwan, Peter Wing Cheung, Chan, Jessica, Choo, Queenie, Lee, Tim K., Kwong, Willie, Huang, Alan, Yoshida, Eric“…Our study examined hepatitis B virus (HBV) awareness and knowledge in Asian communities in British Columbia (BC). …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
831por Chhibar, Purva, Zhu, Ziqiang, Cheedella, Naga K.S., Chaudhry, Rashid, Wang, Jen Chin“…Patient: Male, 61 Final Diagnosis: Ifosfamide induced reactivation of hepatitis B Symptoms: — Medication: Ifosfamide Clinical Procedure: DC ifosfamide and added Tenofovir Specialty: Oncology OBJECTIVE: Unusual clinical course BACKGROUND: Patients receiving cancer treatment are at risk for hepatitis B virus (HBV) reactivation. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
832por Yang, Shigui, Tian, Guo, Cui, Yuanxia, Ding, Cheng, Deng, Min, Yu, Chengbo, Xu, Kaijin, Ren, Jingjing, Yao, Jun, Li, Yiping, Cao, Qing, Chen, Ping, Xie, Tiansheng, Wang, Chencheng, Wang, Bing, Mao, Chen, Ruan, Bing, Jiang, Tian’an, Li, Lanjuan“…Hepatitis B was still a worldwide health problem. This study aimed to conducted a systematic review and meta-analysis to assess a more precise estimation of factors that influence the response to hepatitis B vaccine in adults. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833por de Assis, Danyenne Rejane, Tenore, Simone de Barros, Pinho, João Renato Rebello, Lewi, David Salomão, Ferreira, Paulo Roberto Abrão“…OBJECTIVE: To characterize a chronic hepatitis B cohort based on initial and follow-up clinical evaluations. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
834por Deshpande, Gaurav, Klink, Andrew J., Shenolikar, Rahul, Singer, Joseph, Eisenberg Lawrence, Debra F., Krishnarajah, Girishanthy“…Despite ACIP recommendation and cost-effectiveness established in those 19–59 y old diabetes patients the uptake of Hepatitis B vaccine in diabetes patients is low. There is need to highlight the impact of Hepatitis B virus (HBV) infection in diabetes patients in terms of healthcare utilization and costs to recognize the burden of HBV in this population. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
835“…Cell-free virus is a well-recognized and efficient mechanism for the spread of hepatitis B virus (HBV) infection in the liver. Cell-to-cell transmission (CCT) can be a more efficient means of virus propagation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
836“…BACKGROUND: Hepatitis B virus (HBV) genotype and its role in disease progression and patients’ response to antiviral treatment, is not well studied in Pakistan. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
837“…BACKGROUND: Hepatitis B virus (HBV) is highly contagious and causes liver diseases. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
838“…Hepatitis B virus (HBV) infects approximately 240 million individuals worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
839por Mathew M, Anumol, Kurian, Sumitha C, Varghese, Atul Philip, Oommen, Seema, G, Manoj“…Along with several other factors contributing to HCC, hepatitis B virus (HBV) infection also accounts for a major cause. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
840por Adibi, Peyman, Rezailashkajani, Mohammadreza, Roshandel, Delnaz, Behrouz, Negar, Ansari, Shahin, Somi, Mohammad Hossein, Shahraz, Saeed, Zali, Mohammad Reza“…BACKGROUND: To assess the economic aspects of HBV (hepatitis B virus) transmission prevention for premarriage individuals in a country with cultural backgrounds like Iran and intermediate endemicity of HBV infection. …”
Publicado 2004
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto